Press Releases on November 5, 2020 - EIN Presswire - Press Release Distribution Service

Published on November 5, 2020 - 21:05 GMT

Arcutis Announces Third Quarter 2020 Financial Results and Provides Business Update

Pivotal Phase 3 data in plaque psoriasis anticipated in first quarter of 2021 Pivotal Phase 3 trials in atopic dermatitis anticipated to begin in late 2020 or early 2021 Recent positive Phase 2 data in seborrheic dermatitis supports pipeline advancement in …

Distribution channels: Business & Economy, Technology ...

Published on November 5, 2020 - 21:05 GMT

BigCommerce Announces Third Quarter Financial Results

Third Quarter Total Revenue of $39.7 Million, an Increase of 41% Versus Prior Year Total ARR of $167.0 Million, an Increase of 38% Versus Prior Year AUSTIN, Texas, Nov. 05, 2020 (GLOBE NEWSWIRE) -- BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), …

Distribution channels:

Published on November 5, 2020 - 21:05 GMT

CV Sciences, Inc. Reports Third Quarter 2020 Financial Results

SAN DIEGO, Nov. 05, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced its financial results for the …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 5, 2020 - 21:05 GMT

Codexis Reports Third Quarter 2020 Financial Results

Stronger than expected total revenues of $18.4 million delivered in the quarter Higher sequential sales expected again in the fourth quarter, showing growing momentum as we close 2020 Conference call begins at 4:30 p.m. Eastern time today REDWOOD CITY, …

Distribution channels:

Published on November 5, 2020 - 21:05 GMT

Progyny, Inc. Announces Third Quarter 2020 Results

Reports Record Third Quarter Revenue of $98.9 Million Raises Revenue Guidance to $340.0 to $345.0 Million for Full Year 2020, Reflecting Growth of 48% to 50% Affirms Preliminary View of a Minimum of $525 Million in 2021 Revenue NEW YORK, Nov. 05, 2020 ( …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 5, 2020 - 21:05 GMT

Emergent BioSolutions Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2020 and Updates Full Year ...

Reports strong third quarter and record year to date performance Updates full year guidance — refines revenue ranges and raises profitability ranges GAITHERSBURG, Md., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported …

Distribution channels:

Published on November 5, 2020 - 21:05 GMT

Geron Corporation Reports Third Quarter 2020 Financial Results and Current Events

FOSTER CITY, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today reported financial results for the third quarter ended September 30, 2020. The Company will host a conference …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on November 5, 2020 - 21:05 GMT

Solar Capital Ltd. Announces Quarter Ended September 30, 2020 Financial Results; Declares Quarterly Distribution of $0.41 Per ...

Stable Net Asset Value Acquires Leasing Company to Broaden Specialty Finance Platform NEW YORK, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Solar Capital Ltd. (NASDAQ: SLRC) (the “Company” or “Solar Capital”), today reported net investment income of $14.3 million, …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on November 5, 2020 - 21:05 GMT

iRhythm Technologies Announces Third Quarter 2020 Financial Results

SAN FRANCISCO, Nov. 05, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended September 30 …

Distribution channels:

Published on November 5, 2020 - 21:03 GMT

Infinera Corporation Reports Third Quarter 2020 Financial Results

SUNNYVALE, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Infinera Corporation (NASDAQ: INFN) today released financial results for its third quarter ended September 26, 2020. GAAP revenue for the quarter was $340.2 million compared to $331.6 million in the …

Distribution channels: Business & Economy, Telecommunications ...

Published on November 5, 2020 - 21:03 GMT

Adamas Reports Third Quarter 2020 Financial Results

Third quarter 2020 total revenues of $20.2 million, a 45% increase over third quarter 2019 Third quarter 2020 GOCOVRI® product sales of $19.0 million, a 36% increase over third quarter 2019 Total paid prescriptions of 7,930, a 19% increase over third …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on November 5, 2020 - 21:03 GMT

TrueCar Reports Third Quarter 2020 Financial Results

SANTA MONICA, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- TrueCar, Inc. (NASDAQ: TRUE) today announced its financial results for the third quarter ended September 30, 2020. Third Quarter 2020 Financial Highlights The following financial results reflect …

Distribution channels:

Published on November 5, 2020 - 21:03 GMT

SP Plus Corporation Announces Third Quarter and Nine Month 2020 Results

-- Recovering Business Activity Led to Substantial Improvement in Gross Profit over Q2-- --Year-to Date Operating Cash Flow of $27.9MM and Free Cash Flow of $18.9MM-- --Positive New Business Momentum Reflects Scale and Demand for New Technology Offerings-- …

Distribution channels: Business & Economy, Waste Management ...

Published on November 5, 2020 - 21:02 GMT

Giga-tronics Reports Fiscal 2021 Second Quarter And Six Months Results

DUBLIN, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Giga-tronics Incorporated (OTCQB: GIGA) (the “Company”) reported results for the second quarter and six months ended September 26, 2020. Revenue for the second fiscal quarter was $2.7 million compared to $3 …

Distribution channels: Business & Economy, Electronics Industry ...

Published on November 5, 2020 - 21:02 GMT

Ziopharm Oncology Reports Third Quarter 2020 Financial Results and Provides Corporate Update

– Company plans to file IND for Ziopharm TCR-T program in Q1 of next year for its Library “hotspot” trial – – Eden BioCell on track for IND filing in Taiwan for autologus CAR-T clinical trial this year based on rapid personalized manufacturing; several …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on November 5, 2020 - 21:02 GMT

Nkarta Announces November & December 2020 Investor Conference Schedule

SOUTH SAN FRANCISCO, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced its participation at these …

Distribution channels: Media, Advertising & PR, Technology ...

Published on November 5, 2020 - 21:02 GMT

Editas Medicine Announces Third Quarter 2020 Results and Update

EDIT-101 for LCA10 ‒ BRILLIANCE trial adult low-dose cohort completed EDIT-301 for sickle cell disease ‒ on track for IND filing by end of 2020 EDIT-201 for solid tumors ‒ preclinical data to be presented at SITC and ASH Cash, cash equivalents, and …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on November 5, 2020 - 21:02 GMT

Sarepta Therapeutics to Commence Dosing of the Next Study with Commercial Process Material for the SRP-9001 Gene Therapy Program ...

-- Dosing with SRP-9001 commercial-process material to proceed following discussions with U.S. FDA -- -- Clinical dosing is expected to begin before the end of 2020 -- CAMBRIDGE, Mass., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on November 5, 2020 - 21:02 GMT

Synaptics Reports First Quarter Fiscal 2021 Results

Q1’21 Financial Results and Recent Business Highlights Revenue of $328.4 million GAAP Gross Margin of 41.0 percent; non-GAAP Gross Margin of 49.7 percent GAAP diluted loss per share of $0.08; non-GAAP diluted earnings per share of $1.85 Cash and short-term …

Distribution channels: Business & Economy, Technology ...

Published on November 5, 2020 - 21:02 GMT

Assembly Biosciences Reports Third Quarter 2020 Financial Results and Business Update

SOUTH SAN FRANCISCO, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the …

Distribution channels: